nodes	percent_of_prediction	percent_of_DWPC	metapath
Ritodrine—ADRB2—prostate cancer	0.819	1	CbGaD
Ritodrine—Diethylstilbestrol—AOX1—prostate cancer	0.00204	0.138	CrCbGaD
Ritodrine—Dienestrol—ESR1—prostate cancer	0.00173	0.116	CrCbGaD
Ritodrine—Bezafibrate—PPARA—prostate cancer	0.000938	0.0633	CrCbGaD
Ritodrine—Diethylstilbestrol—COMT—prostate cancer	0.000889	0.0599	CrCbGaD
Ritodrine—Dobutamine—COMT—prostate cancer	0.000843	0.0568	CrCbGaD
Ritodrine—Diethylstilbestrol—ESR2—prostate cancer	0.000829	0.0559	CrCbGaD
Ritodrine—Formoterol—CYP2A6—prostate cancer	0.000583	0.0393	CrCbGaD
Ritodrine—Diethylstilbestrol—CYP2A6—prostate cancer	0.000583	0.0393	CrCbGaD
Ritodrine—Arformoterol—CYP2A6—prostate cancer	0.000583	0.0393	CrCbGaD
Ritodrine—Diethylstilbestrol—CYP19A1—prostate cancer	0.000555	0.0374	CrCbGaD
Ritodrine—Fenoterol—ADRB2—prostate cancer	0.000524	0.0353	CrCbGaD
Ritodrine—Diethylstilbestrol—ESR1—prostate cancer	0.00051	0.0344	CrCbGaD
Ritodrine—Arbutamine—ADRB2—prostate cancer	0.00049	0.0331	CrCbGaD
Ritodrine—Formoterol—ADRB2—prostate cancer	0.000476	0.0321	CrCbGaD
Ritodrine—Arformoterol—ADRB2—prostate cancer	0.000476	0.0321	CrCbGaD
Ritodrine—Dobutamine—ADRB2—prostate cancer	0.000451	0.0304	CrCbGaD
Ritodrine—Diethylstilbestrol—CYP2E1—prostate cancer	0.000414	0.0279	CrCbGaD
Ritodrine—Formoterol—CYP2C19—prostate cancer	0.00041	0.0276	CrCbGaD
Ritodrine—Arformoterol—CYP2C19—prostate cancer	0.00041	0.0276	CrCbGaD
Ritodrine—Labetalol—ADRB2—prostate cancer	0.000348	0.0234	CrCbGaD
Ritodrine—Bezafibrate—CYP1A1—prostate cancer	0.000304	0.0205	CrCbGaD
Ritodrine—Diethylstilbestrol—CYP3A4—prostate cancer	0.000261	0.0176	CrCbGaD
Ritodrine—Bezafibrate—CYP3A4—prostate cancer	0.000194	0.0131	CrCbGaD
Ritodrine—GALR3—Signaling by GPCR—IL2—prostate cancer	8.66e-05	0.000523	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—TERT—prostate cancer	8.63e-05	0.000521	CbGpPWpGaD
Ritodrine—PGD—Metabolism—CYP1A1—prostate cancer	8.51e-05	0.000513	CbGpPWpGaD
Ritodrine—PGD—Metabolism—ERCC2—prostate cancer	8.44e-05	0.000509	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—GNRH1—prostate cancer	8.41e-05	0.000508	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—VIP—prostate cancer	8.41e-05	0.000508	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—HIF1A—prostate cancer	8.25e-05	0.000498	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—RLN2—prostate cancer	8.24e-05	0.000497	CbGpPWpGaD
Ritodrine—PGD—Disease—BAD—prostate cancer	8.22e-05	0.000496	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—GRP—prostate cancer	8.15e-05	0.000492	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—LPAR1—prostate cancer	8.15e-05	0.000492	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—PLCB2—prostate cancer	8.07e-05	0.000487	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—LEP—prostate cancer	8.06e-05	0.000486	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—CAV1—prostate cancer	7.98e-05	0.000482	CbGpPWpGaD
Ritodrine—PGD—Disease—APC—prostate cancer	7.96e-05	0.00048	CbGpPWpGaD
Ritodrine—PGD—Metabolism—MTHFR—prostate cancer	7.93e-05	0.000479	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—KDR—prostate cancer	7.89e-05	0.000476	CbGpPWpGaD
Ritodrine—PGD—Disease—EGF—prostate cancer	7.87e-05	0.000475	CbGpPWpGaD
Ritodrine—PGD—Disease—IRS1—prostate cancer	7.87e-05	0.000475	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—HSD17B1—prostate cancer	7.86e-05	0.000474	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—CTBP2—prostate cancer	7.86e-05	0.000474	CbGpPWpGaD
Ritodrine—PGD—Metabolism—PPARA—prostate cancer	7.78e-05	0.00047	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—PDE4D—prostate cancer	7.69e-05	0.000464	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—ESR1—prostate cancer	7.69e-05	0.000464	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—GNRH1—prostate cancer	7.64e-05	0.000461	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—VIP—prostate cancer	7.64e-05	0.000461	CbGpPWpGaD
Ritodrine—PGD—Disease—GSK3B—prostate cancer	7.64e-05	0.000461	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—PLXNB1—prostate cancer	7.53e-05	0.000455	CbGpPWpGaD
Ritodrine—PGD—Disease—INS—prostate cancer	7.53e-05	0.000454	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—BAD—prostate cancer	7.51e-05	0.000453	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—LPAR1—prostate cancer	7.4e-05	0.000446	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—GRP—prostate cancer	7.4e-05	0.000446	CbGpPWpGaD
Ritodrine—PGD—Disease—CREBBP—prostate cancer	7.38e-05	0.000445	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—PLCB2—prostate cancer	7.32e-05	0.000442	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—GNG5—prostate cancer	7.32e-05	0.000442	CbGpPWpGaD
Ritodrine—PGD—Metabolism—CAV1—prostate cancer	7.32e-05	0.000441	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—PIK3CG—prostate cancer	7.27e-05	0.000439	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—APC—prostate cancer	7.27e-05	0.000439	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—GRPR—prostate cancer	7.25e-05	0.000438	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—IRS1—prostate cancer	7.19e-05	0.000434	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—EGF—prostate cancer	7.19e-05	0.000434	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—CX3CL1—prostate cancer	7.18e-05	0.000433	CbGpPWpGaD
Ritodrine—PGD—Disease—MAP2K1—prostate cancer	7.04e-05	0.000425	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—IL17RD—prostate cancer	7e-05	0.000423	CbGpPWpGaD
Ritodrine—PGD—Disease—PIK3CD—prostate cancer	7e-05	0.000422	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—PDE4D—prostate cancer	6.99e-05	0.000422	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—GSK3B—prostate cancer	6.98e-05	0.000421	CbGpPWpGaD
Ritodrine—PGD—Disease—SERPINE1—prostate cancer	6.92e-05	0.000417	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—INS—prostate cancer	6.88e-05	0.000415	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—CREBBP—prostate cancer	6.74e-05	0.000407	CbGpPWpGaD
Ritodrine—PGD—Disease—FGF2—prostate cancer	6.7e-05	0.000404	CbGpPWpGaD
Ritodrine—PGD—Metabolism—PIK3CG—prostate cancer	6.66e-05	0.000402	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—IGF1—prostate cancer	6.66e-05	0.000402	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—GNG5—prostate cancer	6.65e-05	0.000401	CbGpPWpGaD
Ritodrine—GALR3—Signaling by GPCR—EGFR—prostate cancer	6.62e-05	0.0004	CbGpPWpGaD
Ritodrine—PGD—Disease—NOS3—prostate cancer	6.61e-05	0.000399	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—MAP2K1—prostate cancer	6.43e-05	0.000388	CbGpPWpGaD
Ritodrine—PGD—Disease—JAK2—prostate cancer	6.42e-05	0.000387	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—PIK3CD—prostate cancer	6.39e-05	0.000386	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—PTHLH—prostate cancer	6.38e-05	0.000385	CbGpPWpGaD
Ritodrine—GALR3—GPCR downstream signaling—PIK3CA—prostate cancer	6.33e-05	0.000382	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—SERPINE1—prostate cancer	6.32e-05	0.000381	CbGpPWpGaD
Ritodrine—PGD—Metabolism—INS—prostate cancer	6.31e-05	0.000381	CbGpPWpGaD
Ritodrine—PGD—Disease—MDM2—prostate cancer	6.27e-05	0.000378	CbGpPWpGaD
Ritodrine—GALR3—Signaling by GPCR—KRAS—prostate cancer	6.26e-05	0.000378	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—WNT4—prostate cancer	6.24e-05	0.000377	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—JUP—prostate cancer	6.24e-05	0.000377	CbGpPWpGaD
Ritodrine—PGD—Metabolism—CREBBP—prostate cancer	6.18e-05	0.000373	CbGpPWpGaD
Ritodrine—PGD—Disease—ERBB2—prostate cancer	6.18e-05	0.000373	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—FGF2—prostate cancer	6.12e-05	0.000369	CbGpPWpGaD
Ritodrine—PGD—Disease—PIK3CB—prostate cancer	6.1e-05	0.000368	CbGpPWpGaD
Ritodrine—PGD—Disease—PTGS2—prostate cancer	6.04e-05	0.000365	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—NOS3—prostate cancer	6.04e-05	0.000364	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—ANXA1—prostate cancer	5.99e-05	0.000362	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—RALBP1—prostate cancer	5.95e-05	0.000359	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—MC2R—prostate cancer	5.95e-05	0.000359	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—JAK2—prostate cancer	5.87e-05	0.000354	CbGpPWpGaD
Ritodrine—PGD—Metabolism—PIK3CD—prostate cancer	5.86e-05	0.000353	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—PTHLH—prostate cancer	5.79e-05	0.000349	CbGpPWpGaD
Ritodrine—GALR3—Signaling by GPCR—PIK3CA—prostate cancer	5.75e-05	0.000347	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—MDM2—prostate cancer	5.73e-05	0.000345	CbGpPWpGaD
Ritodrine—PGD—Disease—CDKN1B—prostate cancer	5.72e-05	0.000345	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—PRKACB—prostate cancer	5.67e-05	0.000342	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—ERBB2—prostate cancer	5.65e-05	0.000341	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—CALCA—prostate cancer	5.61e-05	0.000339	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—PIK3CB—prostate cancer	5.57e-05	0.000336	CbGpPWpGaD
Ritodrine—PGD—Metabolism—NOS3—prostate cancer	5.53e-05	0.000334	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—PPP3CA—prostate cancer	5.52e-05	0.000333	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—CXCL12—prostate cancer	5.48e-05	0.000331	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—ANXA1—prostate cancer	5.44e-05	0.000328	CbGpPWpGaD
Ritodrine—PGD—Disease—CTNNB1—prostate cancer	5.41e-05	0.000326	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—CXCL8—prostate cancer	5.35e-05	0.000323	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—PENK—prostate cancer	5.31e-05	0.00032	CbGpPWpGaD
Ritodrine—PGD—Disease—CDKN1A—prostate cancer	5.28e-05	0.000319	CbGpPWpGaD
Ritodrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL8—prostate cancer	5.28e-05	0.000319	CbGpPWpGaD
Ritodrine—PGD—Disease—PTEN—prostate cancer	5.27e-05	0.000318	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—CDKN1B—prostate cancer	5.23e-05	0.000315	CbGpPWpGaD
Ritodrine—GALR3—GPCR downstream signaling—AKT1—prostate cancer	5.17e-05	0.000312	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—CASP3—prostate cancer	5.12e-05	0.000309	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—IL2—prostate cancer	5.12e-05	0.000309	CbGpPWpGaD
Ritodrine—PGD—Metabolism—PIK3CB—prostate cancer	5.11e-05	0.000308	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—CALCA—prostate cancer	5.1e-05	0.000308	CbGpPWpGaD
Ritodrine—GALR3—Signaling by GPCR—IL6—prostate cancer	5.09e-05	0.000307	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—GHR—prostate cancer	5.06e-05	0.000306	CbGpPWpGaD
Ritodrine—PGD—Metabolism—PTGS2—prostate cancer	5.06e-05	0.000305	CbGpPWpGaD
Ritodrine—PGD—Disease—EP300—prostate cancer	5.02e-05	0.000303	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—PRKCQ—prostate cancer	5e-05	0.000302	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—CCND1—prostate cancer	4.99e-05	0.000301	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—CXCL12—prostate cancer	4.98e-05	0.0003	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—CTNNB1—prostate cancer	4.94e-05	0.000298	CbGpPWpGaD
Ritodrine—PGD—Disease—SRC—prostate cancer	4.89e-05	0.000295	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—NRP1—prostate cancer	4.85e-05	0.000293	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—MMP9—prostate cancer	4.84e-05	0.000292	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—CDKN1A—prostate cancer	4.82e-05	0.000291	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—PTEN—prostate cancer	4.81e-05	0.00029	CbGpPWpGaD
Ritodrine—PGD—Disease—STAT3—prostate cancer	4.71e-05	0.000284	CbGpPWpGaD
Ritodrine—GALR3—Signaling by GPCR—AKT1—prostate cancer	4.7e-05	0.000283	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—EP300—prostate cancer	4.59e-05	0.000277	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—VAV3—prostate cancer	4.59e-05	0.000277	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—PRKCQ—prostate cancer	4.54e-05	0.000274	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—GNRH1—prostate cancer	4.51e-05	0.000272	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—VIP—prostate cancer	4.51e-05	0.000272	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—SRC—prostate cancer	4.46e-05	0.000269	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—ITPR1—prostate cancer	4.45e-05	0.000268	CbGpPWpGaD
Ritodrine—PGD—Metabolism—PTEN—prostate cancer	4.41e-05	0.000266	CbGpPWpGaD
Ritodrine—PGD—Disease—MYC—prostate cancer	4.38e-05	0.000264	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—GRP—prostate cancer	4.37e-05	0.000264	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—LPAR1—prostate cancer	4.37e-05	0.000264	CbGpPWpGaD
Ritodrine—PGD—Disease—TGFB1—prostate cancer	4.37e-05	0.000264	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—VEGFA—prostate cancer	4.35e-05	0.000262	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—PLCB2—prostate cancer	4.33e-05	0.000261	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—LRP2—prostate cancer	4.33e-05	0.000261	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—STAT3—prostate cancer	4.31e-05	0.00026	CbGpPWpGaD
Ritodrine—PGD—Disease—EGFR—prostate cancer	4.28e-05	0.000258	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—CX3CL1—prostate cancer	4.24e-05	0.000256	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—P4HB—prostate cancer	4.24e-05	0.000256	CbGpPWpGaD
Ritodrine—PGD—Metabolism—EP300—prostate cancer	4.21e-05	0.000254	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—VAV3—prostate cancer	4.17e-05	0.000251	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—HIST1H2BG—prostate cancer	4.16e-05	0.000251	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—GRB7—prostate cancer	4.13e-05	0.000249	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—PDE4D—prostate cancer	4.13e-05	0.000249	CbGpPWpGaD
Ritodrine—PGD—Disease—KRAS—prostate cancer	4.05e-05	0.000244	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—ITPR1—prostate cancer	4.04e-05	0.000244	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—HIST1H4H—prostate cancer	4.02e-05	0.000243	CbGpPWpGaD
Ritodrine—ADRB2—GPCR ligand binding—CXCL8—prostate cancer	4.02e-05	0.000243	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—MYC—prostate cancer	4e-05	0.000241	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—TGFB1—prostate cancer	3.99e-05	0.000241	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—GNG5—prostate cancer	3.93e-05	0.000237	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—EGFR—prostate cancer	3.91e-05	0.000236	CbGpPWpGaD
Ritodrine—PGD—Disease—PIK3CA—prostate cancer	3.72e-05	0.000224	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—KRAS—prostate cancer	3.7e-05	0.000223	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—PTHLH—prostate cancer	3.42e-05	0.000206	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—TGFBR1—prostate cancer	3.42e-05	0.000206	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—PIK3CA—prostate cancer	3.4e-05	0.000205	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—AKR1C3—prostate cancer	3.36e-05	0.000203	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—PRKACB—prostate cancer	3.35e-05	0.000202	CbGpPWpGaD
Ritodrine—PGD—Disease—IL6—prostate cancer	3.29e-05	0.000199	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—TP53—prostate cancer	3.29e-05	0.000198	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—PPP3CA—prostate cancer	3.26e-05	0.000197	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—THBS1—prostate cancer	3.26e-05	0.000197	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—ANXA1—prostate cancer	3.22e-05	0.000194	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—PRKCZ—prostate cancer	3.16e-05	0.00019	CbGpPWpGaD
Ritodrine—PGD—Metabolism—PIK3CA—prostate cancer	3.11e-05	0.000188	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—PIK3CG—prostate cancer	3.09e-05	0.000186	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—FGFR4—prostate cancer	3.05e-05	0.000184	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—PARP1—prostate cancer	3.05e-05	0.000184	CbGpPWpGaD
Ritodrine—PGD—Disease—AKT1—prostate cancer	3.04e-05	0.000183	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—CALCA—prostate cancer	3.01e-05	0.000182	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—IL6—prostate cancer	3.01e-05	0.000181	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—CXCL12—prostate cancer	2.94e-05	0.000177	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—PIK3CG—prostate cancer	2.8e-05	0.000169	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—AKT1—prostate cancer	2.77e-05	0.000167	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—CASP9—prostate cancer	2.77e-05	0.000167	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—PIK3CD—prostate cancer	2.71e-05	0.000164	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—NGFR—prostate cancer	2.68e-05	0.000162	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—PRKCQ—prostate cancer	2.68e-05	0.000162	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—MAP3K7—prostate cancer	2.65e-05	0.00016	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—FGF10—prostate cancer	2.55e-05	0.000154	CbGpPWpGaD
Ritodrine—PGD—Metabolism—AKT1—prostate cancer	2.54e-05	0.000153	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—JAK2—prostate cancer	2.49e-05	0.00015	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—MAP2K1—prostate cancer	2.48e-05	0.00015	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—PIK3CD—prostate cancer	2.46e-05	0.000149	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—VAV3—prostate cancer	2.46e-05	0.000148	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—TGFBR2—prostate cancer	2.43e-05	0.000146	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—ITPR1—prostate cancer	2.39e-05	0.000144	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—PIK3CB—prostate cancer	2.36e-05	0.000143	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—IGF1R—prostate cancer	2.28e-05	0.000138	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—CXCL8—prostate cancer	2.27e-05	0.000137	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—JAK2—prostate cancer	2.26e-05	0.000136	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—LPL—prostate cancer	2.19e-05	0.000132	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—IL2—prostate cancer	2.17e-05	0.000131	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—PDGFRB—prostate cancer	2.17e-05	0.000131	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—PIK3CB—prostate cancer	2.15e-05	0.00013	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—ITGB3—prostate cancer	2.11e-05	0.000127	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—CXCL8—prostate cancer	2.06e-05	0.000124	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—ERBB3—prostate cancer	2.05e-05	0.000124	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—FGFR2—prostate cancer	2.05e-05	0.000123	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—IL2—prostate cancer	1.97e-05	0.000119	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—TERT—prostate cancer	1.96e-05	0.000119	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—HIF1A—prostate cancer	1.88e-05	0.000113	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—LEP—prostate cancer	1.83e-05	0.000111	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—CAV1—prostate cancer	1.82e-05	0.00011	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—KDR—prostate cancer	1.8e-05	0.000108	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—ESR1—prostate cancer	1.75e-05	0.000106	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—BAD—prostate cancer	1.71e-05	0.000103	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—APC—prostate cancer	1.66e-05	9.99e-05	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—PIK3CG—prostate cancer	1.66e-05	9.99e-05	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—EGF—prostate cancer	1.64e-05	9.87e-05	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—IRS1—prostate cancer	1.64e-05	9.87e-05	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—GSK3B—prostate cancer	1.59e-05	9.58e-05	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—INS—prostate cancer	1.57e-05	9.45e-05	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—CREBBP—prostate cancer	1.53e-05	9.26e-05	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—IGF1—prostate cancer	1.52e-05	9.14e-05	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—EGFR—prostate cancer	1.51e-05	9.1e-05	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—MAP2K1—prostate cancer	1.46e-05	8.84e-05	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—PIK3CD—prostate cancer	1.45e-05	8.78e-05	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—PIK3CA—prostate cancer	1.44e-05	8.7e-05	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—SERPINE1—prostate cancer	1.44e-05	8.68e-05	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—KRAS—prostate cancer	1.42e-05	8.59e-05	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—FGF2—prostate cancer	1.39e-05	8.41e-05	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—NOS3—prostate cancer	1.37e-05	8.29e-05	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—JAK2—prostate cancer	1.34e-05	8.06e-05	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—PIK3CA—prostate cancer	1.31e-05	7.9e-05	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—MDM2—prostate cancer	1.3e-05	7.86e-05	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—ERBB2—prostate cancer	1.29e-05	7.75e-05	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—PIK3CB—prostate cancer	1.27e-05	7.65e-05	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—CXCL8—prostate cancer	1.22e-05	7.35e-05	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—CDKN1B—prostate cancer	1.19e-05	7.18e-05	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—AKT1—prostate cancer	1.18e-05	7.1e-05	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—CASP3—prostate cancer	1.17e-05	7.04e-05	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—IL2—prostate cancer	1.16e-05	7.03e-05	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—IL6—prostate cancer	1.16e-05	6.99e-05	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—CCND1—prostate cancer	1.14e-05	6.85e-05	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—CTNNB1—prostate cancer	1.12e-05	6.78e-05	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—MMP9—prostate cancer	1.1e-05	6.65e-05	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—CDKN1A—prostate cancer	1.1e-05	6.63e-05	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—PTEN—prostate cancer	1.1e-05	6.61e-05	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—AKT1—prostate cancer	1.07e-05	6.45e-05	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—EP300—prostate cancer	1.05e-05	6.31e-05	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—SRC—prostate cancer	1.02e-05	6.13e-05	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—VEGFA—prostate cancer	9.9e-06	5.97e-05	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—STAT3—prostate cancer	9.8e-06	5.91e-05	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—MYC—prostate cancer	9.11e-06	5.49e-05	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—TGFB1—prostate cancer	9.08e-06	5.48e-05	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—EGFR—prostate cancer	8.91e-06	5.37e-05	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—KRAS—prostate cancer	8.41e-06	5.08e-05	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—PIK3CA—prostate cancer	7.73e-06	4.66e-05	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—TP53—prostate cancer	7.48e-06	4.51e-05	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—IL6—prostate cancer	6.85e-06	4.13e-05	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—AKT1—prostate cancer	6.32e-06	3.81e-05	CbGpPWpGaD
